Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.05p
   
  • Change Today:
    -0.25p
  • 52 Week High: 6.00
  • 52 Week Low: 1.30
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 134,319
  • Market Cap: £193.04m
  • RiskGrade: 268
  • Beta: 0.20
Select chart: 1 month | 1 year
 

1 month

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 55.20 (34.20) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-25 64.80 (23.10) (0.70)p n/a n/a n/a n/a 0.0%
30-Jun-26 80.90 (9.70) (0.40)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2025 n/a n/a 65 n/a n/a 85
30-Jun-2026 n/a n/a 81 n/a n/a n/a
 
Earnings
30-Jun-2025 n/a n/a n/a n/a n/a n/a
30-Jun-2026 n/a n/a n/a n/a n/a n/a
 
Dividend
30-Jun-2025 n/a n/a n/a n/a n/a n/a
30-Jun-2026 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 0 0 0
 
Average Rec n/a n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AGY Market Data

Currency UK Pounds
Share Price 4.05p
Change Today -0.25p
% Change -5.81 %
52 Week High 6.00
52 Week Low 1.30
Volume 134,319
Shares Issued 4,766.44m
Market Cap £193.04m
Beta 0.20
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.96% below the market average17.96% below the market average17.96% below the market average17.96% below the market average17.96% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average
Price Trend
38.42% above the market average38.42% above the market average38.42% above the market average38.42% above the market average38.42% above the market average
38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average38.78% above the sector average
Income Not Available
Growth
83.88% below the market average83.88% below the market average83.88% below the market average83.88% below the market average83.88% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average

AGY Dividends

No dividends found

Trades for 13-Sep-2024

Time Volume / Share Price
16:00 20,000 @ 4.30p
16:00 20,000 @ 4.30p
13:41 20,000 @ 4.30p
13:41 20,000 @ 4.30p
13:32 20,000 @ 4.30p

AGY Key Personnel

CEO Manuel Llobet

Top of Page